Latest Capital Raising News

ASF Group Limited reported a $1.58 million cash balance for the December 2024 quarter, highlighting ongoing investments and a director retirement that could influence its strategic direction.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

Evion Group has initiated shipments from its expandable graphite joint venture in India, securing initial sales of A$2 million, while making significant progress on mining licenses and community support for its Maniry Graphite Project in Madagascar.

Aureka Limited has completed a transformative quarter with a $6 million recapitalisation, a strategic rebranding, and the launch of a major diamond drilling program targeting gold resources in Victoria. The company’s strengthened leadership and clean balance sheet set the stage for exploration success in 2025.

Lake Resources NL reported a robust cash position of AUD 22.56 million for Q4 2024, bolstered by a $13.6 million sale of non-core assets and steady progress on the Kachi lithium project’s environmental and engineering milestones.

OzAurum Resources reports a dynamic quarter with fresh drilling targets at Mulgabbie, high-grade gold at Patricia, and promising niobium anomalies in Brazil, supported by a $1 million capital raise.

InteliCare Holdings Limited reported a positive net cash flow of $30,000 for the December quarter, buoyed by a substantial government R&D rebate. The company ends the quarter with $1.26 million in cash, signaling operational stability amid ongoing funding evaluations.

Black Dragon Gold's rezoning application for its flagship Salave Gold Project was rejected by local authorities, posing challenges for mining development. Meanwhile, the company secured a strategic placement raising AUD$712,000 to support ongoing operations.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

Sky Metals has reported strong progress at its Tallebung tin project, completing surface trenching and initiating bulk sampling to validate resource estimates and optimise metallurgical processes. A recent $6 million capital raise will fund expanded drilling and development studies, positioning the company for near-term growth.

Sky Metals Limited reported its December 2024 quarterly cash flow, revealing ongoing exploration expenditures alongside a robust cash position of A$6.375 million.

Mineral Commodities Ltd reported a steep net loss of USD 65.1 million for H1 2024, driven by operational disruptions at its Tormin mine and strategic moves including the sale of its Skaland Graphite Project.